Topic · page 6 of 8

Gout & crystal arthritis

Gout and hyperuricemia, urate-lowering treatment and treat-to-target urate, flare treatment and prophylaxis, comorbidity in gout, calcium pyrophosphate deposition disease and other crystal arthritis

Briefs 201–240 of 301 placed here, newest publication first

Briefs in Gout & crystal arthritis

Newest publication first

Joint Bone Spine29 Nov 2023
Febuxostat dose requirement according to renal function in patients who achieve target serum urate levels: A retrospective cohort study
Cohort study
J Rheumatol15 Nov 2023
Can Smartphone Notifications Help With Gout Management? A Feasibility Study
Randomized controlled trial
Arthritis Care Res (Hoboken)9 Nov 2023
COVID‐19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study
Cohort study
Arthritis Rheumatol9 Nov 2023
Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares
Diagnostic or prognostic study
RMD Open8 Nov 2023
Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
Cohort study
Semin Arthritis Rheum4 Nov 2023
Outcomes of total hip arthroplasty in calcium pyrophosphate deposition disease patients
Cohort study
Semin Arthritis Rheum2 Nov 2023
The statistical challenge of analysing changes in dual energy computed tomography (DECT) urate volumes in people with gout
Diagnostic or prognostic study
Rheumatology (Oxford)31 Oct 2023
Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares
Cohort study
Rheumatology (Oxford)26 Oct 2023
Diagnosis of calcium pyrophosphate crystal deposition disease by ultrasonography: how many and which sites should be scanned?
Diagnostic or prognostic study
Arthritis Res Ther18 Oct 2023
Interleukin-37: associations of plasma levels and genetic variants in gout
Cross-sectional study
Semin Arthritis Rheum13 Oct 2023
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
Meta-analysis
Semin Arthritis Rheum7 Oct 2023
All-cause and specific mortality in patients with gout: A systematic review and meta-analysis
Meta-analysis
Ann Rheum Dis3 Oct 2023
Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink
Cohort study
Rheumatology (Oxford)28 Sep 2023
Patient factors and health outcomes associated with illness perceptions in people with gout
Secondary analysis
Scand J Rheumatol27 Sep 2023
Health-related quality of life by gout severity in women and men with gout in primary care: results from a questionnaire study in Western Sweden
Cross-sectional study
Rheumatology (Oxford)9 Sep 2023
The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy
Secondary analysis
Arthritis Res Ther7 Sep 2023
Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study
Randomized controlled trial
Lancet Rheumatol31 Aug 2023
Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY
Cohort study
Ann Rheum Dis31 Aug 2023
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial
Randomized controlled trial
Joint Bone Spine25 Aug 2023
Validation of gout diagnosis in electronic primary care medical records: A population-based study
Cross-sectional study
Rheumatology (Oxford)23 Aug 2023
Association between the initial dose urate-lowering drugs and gout flares in adult males with gout
Cohort study
Lancet Rheumatol8 Aug 2023
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial
Randomized controlled trial
JAMA Netw Open1 Aug 2023
Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes
Cohort study
Arthritis Rheumatol26 Jul 2023
The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease
Diagnostic or prognostic study
Ann Rheum Dis26 Jul 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
Diagnostic or prognostic study
Arthritis Res Ther25 Jul 2023
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
Meta-analysis
Ann Intern Med25 Jul 2023
Comparative Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study
Cohort study
Arthritis Res Ther19 Jul 2023
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Research article
Rheumatology (Oxford)14 Jul 2023
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout
Randomized controlled trial
Arthritis Rheumatol12 Jul 2023
Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population‐Based , Prospective Study and Mendelian Randomization Analysis
Cohort study
Joint Bone Spine11 Jul 2023
Test characteristics of Raman spectroscopy integrated with polarized light microscopy for the diagnosis of acute gouty arthritis
Diagnostic or prognostic study
Lancet Rheumatol5 Jul 2023
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level
Cross-sectional study
Scand J Rheumatol3 Jul 2023
Beliefs about medicines in gout patients: results from the NOR-Gout 2-year study
Cohort study
Arthritis Care Res (Hoboken)26 Jun 2023
Serum Urate Monitoring Among Older Adults With Gout: Initiating Urate‐Lowering Therapy in Ontario, Canada
Cohort study
Rheumatology (Oxford)20 Jun 2023
Acute calcium pyrophosphate crystal arthritis is associated with an increased rate of hip and knee joint surgery
Cohort study
Arthritis Rheumatol15 Jun 2023
Risk of Venous Thromboembolism With Gout Flares
Cohort study
RMD Open9 Jun 2023
Filling gaps in female gout: a cross-sectional study of comorbidities in 192 037 hospitalised patients
Cross-sectional study
Arthritis Rheumatol25 May 2023
Lowering Serum Urate With Urate‐Lowering Therapy to Target and Incident Fracture Among People With Gout
Cohort study
Rheumatology (Oxford)22 May 2023
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis
Cohort study
Arthritis Care Res (Hoboken)16 May 2023
Impact of Television Depictions of Gout on Perceptions of Illness: A Randomized Controlled Trial
Randomized controlled trial

All 301 Briefs in ExploreShowing Briefs 201–240 of 301, newest first